바이러스 여과 시장 보고서(2026년)
Virus Filtration Global Market Report 2026
상품코드 : 1933699
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,691,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,672,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,652,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이러스 여과 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 59억 4,000만 달러에서 2026년에는 66억 8,000만 달러로, CAGR 12.5%로 성장할 것으로 예상됩니다. 지난 몇 년간의 성장 요인으로는 바이오의약품 제조 확대, 바이러스 안전성에 대한 규제 당국의 강조, 백신 생산 확대, CRO(임상시험수탁기관)에 대한 아웃소싱 증가, 첨단 여과 기술 도입 등을 꼽을 수 있습니다.

바이러스 여과 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 108억 1,000만 달러에 달하고, CAGR은 12.8%를 기록할 전망입니다. 예측 기간의 성장 요인으로는 세포 및 유전자 치료의 확대, 바이오 제조 역량 강화, 규제 기준 강화, 바이오의약품 파이프라인 증가, 무공해 생산에 대한 수요 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 바이오의약품의 안전성에 대한 수요 증가, 유전자 및 세포 치료제 생산 확대, 일회용 여과 시스템 채택 증가, 공정 검증에 대한 관심 증가, 백신 생산에 대한 사용 증가 등을 들 수 있습니다.

만성질환의 증가는 바이러스 여과 시장의 성장을 뒷받침할 것으로 예상됩니다. 만성질환이란 지속적인 의료적 치료가 필요하거나 일상생활을 제한하는 장기적인 상태를 말합니다. 바이러스 여과는 생물학적 제제 및 의료 제품 제조 과정에서 바이러스를 효과적으로 제거하여 감염 및 만성질환의 위험 감소에 기여합니다. 예를 들어, 2023년 6월 미국 공중보건 연구기관인 건강지표평가연구소(IHME)가 발표한 보고서에 따르면, 전 세계적으로 5억 명 이상이 당뇨병을 앓고 있으며, 2050년에는 그 수가 13억 명에 달할 것으로 예측하고 있습니다. 따라서 만성질환의 유병률 증가가 바이러스 여과 기술에 대한 수요를 주도하고 있습니다.

제약 산업의 수요 증가도 바이러스 여과 시장의 성장을 촉진할 것으로 예상됩니다. 제약 산업은 의약품과 치료법을 연구, 개발, 제조, 판매하는 산업입니다. 바이러스 여과 기술은 바이오의약품, 백신, 첨단 치료법 생산에 매우 중요한 역할을 하며, 제품의 안전성, 유효성 및 바이러스 오염 물질 제거를 보장합니다. 예를 들어, 2024년 5월 미국 소재 의약품 분석 회사인 IQVIA Inc.는 2023년 미국 내 의약품 지출이 순가격 기준으로 4,350억 달러에 달했다고 보고했습니다. 2028년까지 의약품 사용량 증가와 혁신적인 치료법 도입으로 인해 순 지출이 1,270억 달러 증가할 것으로 예상됩니다. 다만, 특허 만료 및 규제 변경에 따른 가격 하락으로 인해 그 증가분은 일부 상쇄될 것으로 예상됩니다. 따라서 지속적으로 성장하고 있는 제약 부문은 바이러스 여과 시장의 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM
영문 목차

영문목차

Virus filtration is a method employed to physically remove potential viruses from manufacturing process streams, serving as a crucial step in ensuring the purity of medicines. These filters act as a primary defense against the introduction of adventitious viruses into this important category of pharmaceuticals. What sets virus filters apart is that their manufacturers have rigorously evaluated and optimized their robustness and efficiency in virus removal performance. Additionally, they have developed integrity tests correlated to virus removal.

The main types of virus filtration include kits and reagents, services, filtration systems, and other related categories. Kits are sterile tubing systems designed for the transfer of radioactive proteins between a labeling (reaction) vessel and a purification column, facilitated by peristaltic pumps. Reagents, on the other hand, are substances or compounds that can facilitate a reaction, and they find wide application in various tests. In the context of virus filtration, reagents are integral components of test kits. The use of virus filtration extends across pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Its applications span diverse areas such as medical devices, water purification, air purification, biologicals, vaccines and therapeutics, blood and blood products, as well as cellular and gene therapy products.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the virus filtration market by increasing the cost of imported membranes, filtration housings, testing reagents, and specialized consumables. Filtration systems and kits are most impacted, particularly in North America and Europe. Higher costs have influenced procurement strategies for biopharma companies. At the same time, tariffs have encouraged regional manufacturing of filtration components and strengthened local supply chains.

The virus filtration market research report is one of a series of new reports from The Business Research Company that provides virus filtration market statistics, including virus filtration industry global market size, regional shares, competitors with a virus filtration market share, detailed virus filtration market segments, market trends and opportunities, and any further data you may need to thrive in the virus filtration industry. This virus filtration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virus filtration market size has grown rapidly in recent years. It will grow from $5.94 billion in 2025 to $6.68 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to growth in biologics manufacturing, regulatory focus on viral safety, expansion of vaccine production, increased outsourcing to CROs, adoption of advanced filtration technologies.

The virus filtration market size is expected to see rapid growth in the next few years. It will grow to $10.81 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth in cell and gene therapies, expansion of biomanufacturing capacity, stricter regulatory standards, rising biologics pipeline, demand for contamination free production. Major trends in the forecast period include rising demand for biopharmaceutical safety, expansion of gene and cell therapy manufacturing, growing adoption of single use filtration systems, increased focus on process validation, rising use in vaccine production.

The increasing number of chronic diseases is expected to support the growth of the virus filtration market. Chronic diseases are long-term conditions that require ongoing medical attention or limit daily activities. Virus filtration helps reduce the risk of infectious and chronic diseases by effectively removing viruses during the production of biological and medical products. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research organization, reported that more than half a billion people worldwide were living with diabetes, with projections indicating the number could rise to 1.3 billion by 2050. Therefore, the growing prevalence of chronic diseases is driving demand for virus filtration technologies.

The increasing demand within the pharmaceutical industry is also expected to drive the virus filtration market. The pharmaceutical industry conducts research, development, production, and marketing of medications and therapies. Virus filtration plays a crucial role in manufacturing biopharmaceuticals, vaccines, and advanced therapies, ensuring that products are safe, effective, and free from viral contaminants. For instance, in May 2024, IQVIA Inc., a US-based pharmaceutical analytics company, reported that U.S. medicine spending reached $435 billion at net price levels in 2023. By 2028, net spending is projected to grow by $127 billion, driven by increased medicine usage and adoption of innovative therapies, though partially offset by lower prices resulting from patent expiries and regulatory changes. Therefore, the growing pharmaceutical sector is contributing to the expansion of the virus filtration market.

Major companies in the virus filtration market are focusing on next-generation high-flux filtration technologies to improve bioprocess efficiency, increase throughput, and maintain robust viral safety. High-flux filtration allows liquids to pass through membranes at faster rates while preserving separation performance, reducing processing time and improving productivity. For example, in October 2024, Asahi Kasei Medical, a Japan-based chemical company, introduced Planova FG1, a next-generation virus removal filter aimed at improving biopharmaceutical manufacturing efficiency. Planova FG1 provides approximately seven times higher flux than the company's BioEX model, significantly reducing filtration time while maintaining strong viral removal performance-even during process interruptions. Early evaluations showed high protein recovery and consistent results without requiring prefiltration. Designed to be compatible with standard CIP and SIP systems, FG1 integrates easily into existing production setups. The product line will continue to expand to support rising global demand for biopharmaceuticals.

Major companies operating in the virus filtration market are Merck & Company Inc., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International Inc., Sartorius AG, Asahi Kasei Medical Co. Ltd., WuXi AppTec, Danaher Corporation, Sigma-Aldrich Corporation, Pendotech, Purafil Inc., Parker Hannifin Corporation, Eaton Corporation, Freudenberg Group, Entegris Inc., Meissner Filtration Products Inc., Koch Membrane Systems Inc., Graver Technologies LLC, Amazon Filters Ltd., Cobetter Filtration Equipment Co. Ltd., Sterlitech Corporation, Membrane Solutions LLC, Advantec MFS Inc., GVS Group, Porvair Filtration Group

North America was the largest region in the virus filtration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virus filtration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the virus filtration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The virus filtration market consists of revenues earned by entities by providing virus filtering services to effectively remove viruses in various processes. The market value includes the value of related goods sold by the service provider or included within the service offering. The virus filtration market also includes sales of filters and systems used to remove viruses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virus Filtration Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses virus filtration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for virus filtration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The virus filtration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Virus Filtration Market Characteristics

3. Virus Filtration Market Supply Chain Analysis

4. Global Virus Filtration Market Trends And Strategies

5. Virus Filtration Market Analysis Of End Use Industries

6. Virus Filtration Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Virus Filtration Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Virus Filtration Total Addressable Market (TAM) Analysis for the Market

9. Virus Filtration Market Segmentation

10. Virus Filtration Market Regional And Country Analysis

11. Asia-Pacific Virus Filtration Market

12. China Virus Filtration Market

13. India Virus Filtration Market

14. Japan Virus Filtration Market

15. Australia Virus Filtration Market

16. Indonesia Virus Filtration Market

17. South Korea Virus Filtration Market

18. Taiwan Virus Filtration Market

19. South East Asia Virus Filtration Market

20. Western Europe Virus Filtration Market

21. UK Virus Filtration Market

22. Germany Virus Filtration Market

23. France Virus Filtration Market

24. Italy Virus Filtration Market

25. Spain Virus Filtration Market

26. Eastern Europe Virus Filtration Market

27. Russia Virus Filtration Market

28. North America Virus Filtration Market

29. USA Virus Filtration Market

30. Canada Virus Filtration Market

31. South America Virus Filtration Market

32. Brazil Virus Filtration Market

33. Middle East Virus Filtration Market

34. Africa Virus Filtration Market

35. Virus Filtration Market Regulatory and Investment Landscape

36. Virus Filtration Market Competitive Landscape And Company Profiles

37. Virus Filtration Market Other Major And Innovative Companies

38. Global Virus Filtration Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Virus Filtration Market

40. Virus Filtration Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기